Lung cancer recurrence prediction method based on DNA methylation of tissue-specific enhancement subregion
A tissue-specific, predictive method technology, applied in the field of biomedicine, can solve the problems of unreasonable prediction of recurrence of non-small cell lung cancer, and achieve good prediction efficiency and good uniformity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0051] Embodiment A method for predicting recurrence of lung cancer based on DNA methylation of tissue-specific enhancer regions, the specific process is as follows:
[0052] (1), such as figure 1 As shown, stage IB / IIA non-small cell lung cancer cases, including relapsed and non-relapsed patients with matched clinical information, were collected, DNA samples were extracted, and simplified bisulfite sequencing was performed.
[0053] (2) In order to enable the lung cancer recurrence model to be applied to the 450K chip platform at the same time, we screened the methylation sites that can be detected by the chip probes for subsequent model establishment. It should be noted that theoretically, this model can be applied to any technology that can detect methylation sites / intervals, so in addition to 450K, the same can be achieved in other methylation detection technologies (such as RRBS, WGBS and 850K). Purpose.
[0054] (3) We divided the samples into high-risk group and low-r...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com